Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Fahimfar, Noushin ^a   Khalili, Davood ^a,b   Mohebi, Reza ^a   Azizi, Fereidoun ^c   Hadaegh, Farzad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic kidney disease; Diabetes; Hypertension; Population attributable fraction; Stroke

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGE DISTRIBUTION; BRAIN ISCHEMIA; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; IRAN; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX DISTRIBUTION; STROKE;

EID: 84866781314     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-117     Document Type: Article

References (29)

1. Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved?. Lancet Neurol 2007, 6:94-97. 10.1016/S1474-4422(07)70007-8, 17239789.
2. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007, 6:182-187. 10.1016/S1474-4422(07)70031-5, 17239805.
3. Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M, Ghandehary K, Farzadfard MT, Kiani R, Panahandeh M, Thrift AG. Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke 2010, 41:e3-e10. 10.1161/STROKEAHA.109.559708, 19926844.
4. Tran J, Mirzaei M, Anderson L, Leeder SR. The epidemiology of stroke in the Middle East and North Africa. J Neurol Sci 2010, 295:38-40. 10.1016/j.jns.2010.05.016, 20541222.
5. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
6. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:517-584. 10.1161/STR.0b013e3181fcb238, 21127304.
7. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123. 10.1016/S0140-6736(10)60834-3, 20561675.
8. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010, 341:c4249. 10.1136/bmj.c4249, 2948650, 20884696.
9. Hosseini AA, Sobhani-Rad D, Ghandehari K, Benamer HT. Frequency and clinical patterns of stroke in Iran - Systematic and critical review. BMC Neurol 2010, 10:72. 10.1186/1471-2377-10-72, 2936882, 20731823.
10. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10:5. 10.1186/1745-6215-10-5, 2656492, 19166627.
11. Harati H, Hadaegh F, Momenan AA, Ghanei L, Bozorgmanesh MR, Ghanbarian A, Mirmiran P, Azizi F. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prevent Med 2010, 38:628-636. e621..
12. Hadaegh F, Zabetian A, Sarbakhsh P, Khalili D, James WP, Azizi F. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes (Lond) 2009, 33:1437-1445.
13. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
15. World Health Organization Cerebrovascular disorders: a clinical and research classification 1978, whqlibdoc.who.int/offset/WHO_OFFSET_43.pdf., World Health Organization.
16. D'Agostino RBNB. Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures 2004, Netherlands: Elsevier.
17. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998, 88:15-19. 10.2105/AJPH.88.1.15, 1508384, 9584027.
18. Rothman K, Greenland S, Lash T. Modern Epidemiology 2008, Third Ed: Lippincott Williams & Wilkins.
19. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171. 10.1161/CIRCULATIONAHA.106.179918, 17194875.
20. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010, 375:1296-1309. 10.1016/S0140-6736(09)62004-3, 20382326.
21. Kurella Tamura M, Xie D, Yaffe K, Cohen DL, Teal V, Kasner SE, Messe SR, Sehgal AR, Kusek J, DeSalvo KB, et al. Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol 2011, 6:248-256. 10.2215/CJN.02660310, 3052213, 20930087.
22. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004, 35:776-785. 10.1161/01.STR.0000116869.64771.5A, 14976329.
23. Lawson ML, Gerstein HC, Tsui E, Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diabetes Care 1999, 22(Suppl 2):B35-B39.
24. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008, 359:1565-1576. 10.1056/NEJMoa0806359, 18784091.
25. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989, 298:789-794. 10.1136/bmj.298.6676.789, 1836102, 2496858.
26. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000. 3284229, 19903920.
27. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
28. Vergouwen MD, Vermeulen M, Roos YB. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2009, 72:1447. author reply 1447-1448., 10.1212/01.wnl.0000346744.56398.e5, 19380708.
29. Wu CY, Wu HM, Lee JD, Weng HH. Stroke risk factors and subtypes in different age groups: a hospital-based study. Neurology India 2010, 58:863-868. 10.4103/0028-3886.73747, 21150050.